Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development.
Relation Therapeutics has raised $26.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2025.
Relation Therapeutics's investors include Khosla Ventures, ARK Investment Management, Novartis, Deerfield Management, NVentures.
Relation Therapeutics is headquartered in London, United Kingdom.
Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development.
Relation Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Relation Therapeutics — Funding & Investors." VCBacked, December 9, 2025, https://www.vcbacked.co/company/relation-therapeutics. Accessed August 14, 2026.
VCBacked. (2025). Relation Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/relation-therapeutics
{{cite web |title=Relation Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/relation-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated